Healthcare IT News October 21, 2024
Jessica Hagen

The Agency says AI can transform multiple aspects of healthcare, but it is difficult to fully oversee and regulate the technology without the assistance of all sectors involved.

The Food and Drug Administration (FDA) has released its perspective on regulating AI in healthcare and biomedicine, stating that oversight needs to be coordinated across all regulated industries, international organizations and the U.S. government.

The Agency says it regulates industries that distribute their products to the global market, and therefore U.S. regulatory standards must be compatible with international standards.

It highlighted that it is working to accomplish this by coleading an AI working group of the International Medical Device Regulators Forum that both promotes AI best practices globally and leads...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Regulations, Technology
Related Articles:
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
4 takeaways from the FDA’s first digital health advisory committee
FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight
Diversity data in the US: Understanding the FDA’s push for more representation in clinical trials

Share This Article